111 (YI) Net Income towards Common Stockholders (2017 - 2025)

111's (YI) quarterly Net Income towards Common Stockholders came in at -$2.3 million in Q4 2025, up 14.64% year-on-year from -$2.0 million in Q4 2024, and down 27.4% quarter-over-quarter from -$1.8 million in Q3 2025.

111 (YI) Net Income towards Common Stockholders (2017 - 2025) Analysis & Trends

111 has disclosed Net Income towards Common Stockholders across 9 years of filings, most recently posting -$2.3 million for Q4 2025.

  • Net Income towards Common Stockholders for Q4 2025 came in at -$2.3 million, up 14.64% year-over-year; the trailing twelve-month figure through Dec 2025 was -$9.3 million (down 3.42% YoY), and the FY2025 annual result was -$9.5 million, down 7.03% from the prior year.
  • Net Income towards Common Stockholders came in at -$2.3 million for Q4 2025 at 111, down from -$1.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$1.8 million in Q3 2025 to a low of -$39.1 million in Q3 2021.
  • The 5-year median for Net Income towards Common Stockholders is -$10.3 million (2023), against an average of -$11.9 million.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 144.46% in 2021 and jumped 90.83% in 2024, its largest moves.
  • 111's Net Income towards Common Stockholders stood at -$17.5 million in 2021, then gained by 5.05% to -$16.6 million in 2022, then slumped by 78.6% to -$29.6 million in 2023, then surged by 90.83% to -$2.7 million in 2024, then increased by 14.64% to -$2.3 million in 2025.
  • The last three Net Income towards Common Stockholders figures came in at -$2.3 million (Q4 2025), -$1.8 million (Q3 2025), and -$2.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn 1.86 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 1.63 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn 380.00 Mn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn -541.00 Mn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn -
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn -9.08 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn -2.32 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn -2.81 Mn
10 Cellyan Biotechnology 5.69 -2.48 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.32 Mn
Sep 30, 2025 -1.82 Mn
Jun 30, 2025 -2.73 Mn
Mar 31, 2025 -2.43 Mn
Dec 31, 2024 -2.72 Mn
Sep 30, 2024 -2.44 Mn
Jun 30, 2024 -1.93 Mn
Mar 31, 2024 -1.91 Mn
Dec 31, 2023 -29.63 Mn
Sep 30, 2023 -12.79 Mn
Jun 30, 2023 -7.89 Mn
Mar 31, 2023 -4.63 Mn
Dec 31, 2022 -16.59 Mn
Sep 30, 2022 -13.61 Mn
Jun 30, 2022 -14.22 Mn
Mar 31, 2022 -17.41 Mn
Dec 31, 2021 -17.47 Mn
Sep 30, 2021 -39.09 Mn
Jun 30, 2021 -24.62 Mn
Mar 31, 2021 -22.38 Mn